![Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004223010805-gr1.jpg)
Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers - ScienceDirect
![TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine](https://www.thelancet.com/cms/attachment/582b61e3-c8c7-499e-9785-188e8a092ad3/gr1_lrg.jpg)
TP53 mutational landscape of metastatic head and neck cancer reveals patterns of mutation selection - eBioMedicine
![Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma](https://www.spandidos-publications.com/article_images/ol/19/4/ol-19-04-2739-g00.jpg)
Implications of driver genes associated with a high tumor mutation burden identified using next‑generation sequencing on immunotherapy in hepatocellular carcinoma
![Overall survival curves of patients with p53 mutation results. (A) p53... | Download Scientific Diagram Overall survival curves of patients with p53 mutation results. (A) p53... | Download Scientific Diagram](https://www.researchgate.net/publication/5822095/figure/fig1/AS:601681008021550@1520463339936/Overall-survival-curves-of-patients-with-p53-mutation-results-A-p53-mutation-results.png)
Overall survival curves of patients with p53 mutation results. (A) p53... | Download Scientific Diagram
![Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway](https://www.ijbs.com/v18/p2419/toc.jpg)
Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway
![TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife](https://iiif.elifesciences.org/lax/17929%2Felife-17929-fig1-figsupp2-v4.tif/full/1500,/0/default.jpg)
TP53 exon-6 truncating mutations produce separation of function isoforms with pro-tumorigenic functions | eLife
![Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/90dcaaaa-408c-4a61-9b65-1dc422dcfb2b/mgg31001-toc-0001-m.jpg?trick=1699980891962)
Gain of function in somatic TP53 mutations is associated with immune‐rich breast tumors and changes in tumor‐associated macrophages - Behring - 2019 - Molecular Genetics & Genomic Medicine - Wiley Online Library
![LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma](https://www.jcancer.org/ms/getimage.php?name=jcav12p0217g005.jpg)
LRP1B or TP53 mutations are associated with higher tumor mutational burden and worse survival in hepatocellular carcinoma
![Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-35727-y/MediaObjects/41467_2022_35727_Fig1_HTML.png)
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosis | Nature Communications
![Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-023-10775-9/MediaObjects/12885_2023_10775_Fig3_HTML.png)
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text
![Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S000649712100985X-grabsf1.jpg)
Low-burden TP53 mutations in CLL: clinical impact and clonal evolution within the context of different treatment options - ScienceDirect
![Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.abn9155/asset/f93e4759-81c1-41bb-ac83-4b3dd30f8f14/assets/images/large/scitranslmed.abn9155-f1.jpg)
Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties | Science Translational Medicine
![Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12885-023-10775-9/MediaObjects/12885_2023_10775_Fig4_HTML.png)
Evaluating the prognostic significance of p53 and TP53 mutations in HPV-negative hypopharyngeal carcinoma patients: a 5-year follow-up retrospective study | BMC Cancer | Full Text
![TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram TP53 mutation spectrum in primary colorectal cancers. a Proportion of... | Download Scientific Diagram](https://www.researchgate.net/publication/333120263/figure/fig1/AS:759000865980418@1557971316867/TP53-mutation-spectrum-in-primary-colorectal-cancers-a-Proportion-of-TP53-mutation.png)